Variant report
Variant | esv1962014 |
---|---|
Chromosome Location | chr2:114151145-114153772 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs28665757 | chr2:114151155-114151156 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs369980759 | chr2:114151156-114151157 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs28658130 | chr2:114151200-114151201 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs545718809 | chr2:114151227-114151228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs201618797 | chr2:114151235-114151236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs559580981 | chr2:114151288-114151289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs528421861 | chr2:114151290-114151291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs548524039 | chr2:114151300-114151301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs13411628 | chr2:114151304-114151305 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs530124616 | chr2:114151309-114151310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs550203560 | chr2:114151318-114151319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs111452975 | chr2:114151319-114151320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs143414013 | chr2:114151346-114151347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs546091577 | chr2:114151354-114151355 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs183523665 | chr2:114151361-114151362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs13385481 | chr2:114151364-114151365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs556770916 | chr2:114151390-114151391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs554860408 | chr2:114151393-114151394 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs574055270 | chr2:114151399-114151400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536693167 | chr2:114151400-114151401 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs13424823 | chr2:114151403-114151404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs576899843 | chr2:114151496-114151497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs373010012 | chr2:114151586-114151587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs373831064 | chr2:114151927-114151928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs78318021 | chr2:114152011-114152012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs9679496 | chr2:114152071-114152072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs9679368 | chr2:114152092-114152093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs9677249 | chr2:114152137-114152138 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs9679105 | chr2:114152269-114152270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs10469813 | chr2:114152413-114152414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs62159965 | chr2:114152995-114152996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545956740 | chr2:114153463-114153464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs559252533 | chr2:114153478-114153479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs200558418 | chr2:114153605-114153606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs573086626 | chr2:114153656-114153657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs181051078 | chr2:114153679-114153680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs576708633 | chr2:114153693-114153694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs561968183 | chr2:114153712-114153713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs530116348 | chr2:114153717-114153718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs185637011 | chr2:114153731-114153732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542233600 | chr2:114153735-114153736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Ischaemic stroke | 16980335 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Nephronophthisis | 17901113 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:114148400-114165000 | Weak transcription | A549 | lung |
2 | chr2:114151000-114151200 | Enhancers | Primary monocytes fromperipheralblood | blood |